Company / Free Cash Flow
10x Genomics, Inc. Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$130.1M
FY2025
5-year range
-$165.3M / $130.1M
FY2021-FY2025
Trend
+2371.2%
vs FY2024
Sector context
#73 of 145
Health Care
What the data says
Free Cash Flow changed +2371% YoY in FY2025, a notable deviation from the 8-year average annual change of -110%.
Based on SEC 10-K filings.
$130M in FY2025.
Improved from -$64M to $130M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 145 in Health CareTop 50% of 145This company $130.1M Sector average $770.9M
▼
-83.1% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 2371.2% year-over-year.
- Ranks #73 out of 145 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $130.1M | +2371.2% |
| FY2024 | -$5.7M | +91.0% |
| FY2023 | -$63.8M | +61.4% |
| FY2022 | -$165.3M | -34.7% |
| FY2021 | -$122.7M | +51.8% |
| FY2020 | -$254.6M | -3037.0% |
| FY2019 | -$8.1M | +90.2% |
| FY2018 | -$82.7M | -472.1% |
| FY2017 | -$14.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026